Occupational Hygiene Science and Its Application in Occupational Health Policy^ at Home and Abroad*
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
OCCUPATIONAL MEDICINE PROGRAM HANDBOOK October 2005
U.S. DEPARTMENT OF THE INTERIOR OFFICE OF OCCUPATIONAL HEALTH AND SAFETY OCCUPATIONAL MEDICINE PROGRAM HANDBOOK October 2005 This Occupational Medicine Program Handbook was prepared by the U.S. Department of the Interior’s Office of Occupational Health and Safety, in consultation with the U.S. Office of Personnel Management and the U.S. Public Health Service’s Federal Occupational Health service. This edition of the Handbook represents the continuing efforts of the contributing agencies to improve occupational health services for DOI employees. It reflects the comments and suggestions offered by users over the years since it was first introduced, and addresses the findings, concerns, and recommendations summarized in the final report of a program review completed in 1994 by representatives of the Uniformed Services University of the Health Sciences. That report, entitled “A Review of the Occupational Health Program of the United States Department of the Interior,” was prepared by Margaret A.K. Ryan, M.D., M.P.H., Gail Gullickson, M.D., M.P.H., W. Garry Rudolph, M.D., M.P.H., and Elizabeth Odell. The report led to the establishment of the Department’s Occupational Health Reinvention Working Group, composed of representatives from the DOI bureaus and operating divisions. The recommendations from the Reinvention Working Group final report, published in May of 1996, were addressed and are reflected in what became this Handbook. First published in 1997, the Handbook underwent a major update in July, 2000. This 2005 version of the Handbook incorporates the updates and enhancements that have been made in DOI policies and occupational medicine practice since the last edition. -
Role and Value of the Corporate Medical Director
ACOEM GUIDANCE STATEMENT Role and Value of the Corporate Medical Director J. Brent Pawlecki, MD, MMM, Wayne N. Burton, MD, Cherryl Christensen, DO, MS, K. Andrew Crighton, MD, Richard Heron, MB, ChB, FRCP, T. Warner Hudson, MD, Pamela A. Hymel, MD, MPH, and David Roomes, FFOM, FACOEM, ACOEM Corporate Medical Directors Section Task Force accreditation in occupational medicine or the more preferred double The role of the corporate medical director (CMD) has evolved over the last certification in occupational medicine, and another board such as 300 years since Ramazzini first identified diseases of Italian workers in the 01/04/2019 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3VFjldD2uL9p7SMbj5XQFggscApMlmW/UgXNoK/5MD7Gq31Q2YQqh0A== by https://journals.lww.com/joem from Downloaded Downloaded internal medicine or family medicine. Further qualifications such as a early 1700s. Since then, there has been a gradual blurring of the boundaries master of public health or masters-level degree in environmental between private and workplace health concerns. Today’s CMD must have health, business administration, or law are highly desirable, including from intimate knowledge of their corporation’s industry and the businesses that knowledge of epidemiology, biostatistics, population health manage- https://journals.lww.com/joem they support, particularly the occupational and environmental programs that ment, business management, and regulatory aspects of employee comply with all local, state, and/or national standards and regulations. health. CMDs should also remain active in their relevant professional Leading companies not only measure compliance with such standards but health organizations to demonstrate that they are remaining current in also may hold programs to their own internal corporate global standards even medicine. -
Environmental Health
Environmental "ealth In Minnesota '·' ! .\ " ' Strengthening Pabllc Healtll Leadership In Environmental Health Il Il I j fml Minnesota · lIDJ Department of Health lli&ilhl ~==~-:.i:.ltft -------- Janaary199J '.~ • - " . Environmental Health In Minnesota Strengthening Public Health Leadership In Environmental Health A Report of the Environmental Health Work Group of the State Community Health Services Advisory Committee Approved December 4, 1992 Published by the ., ,f Minnesota Department of Health Environmental Health In Minnesota Strengthening Public Health Leadership In Environmental Health Table of Contents Introduction . i Work Group charge and membership . ii Part I Background and Recommendations . 1 Contributions of Public Health In Environmental Health and Protection . 3 State Roles In Environmental Health . 6 Local Roles In Environmental Health . 7 Recommendations . 10 Part II Framework For Deciding How to Organize Environmental Services . 13 Keeping a Public Health Perspective In Environmental Health and Protection . 23 Part Ill Profile of Environmental Health In Minnesota . 25 Profile of State Environmental Health . 25 Profile of Local Environmental Health . 26 Current Organization of Local Environmental Health Programs . 31 Part IV Related Documents MACHA Position Paper Current Roles and Challenges of Local Health Departments In Environmental Health, NACHO Directory of State Environmental Health Programs (published separately) Cover art by Kathy Marschall Minnesota Department of Health ) Community Health Seroices Division \ ' ···~ )' Environmental Health In Minnesota + i Introduction Environmental heal.th has been an integral part of the public health mission for over a century. With the rest of public health, environmental health shares a basis In science and a focus on protecting and promoting the health of the public. In the past twenty years an explosion of environmental laws has given greater visibility to . -
Standards, Principles and Approaches in Occupational Health Services
STANDARDS, PRINCIPLES AND APPROACHES IN OCCUPATIONAL HEALTH SERVICES Jorma Rantanen, Igor A. Fedotov This article is based on the standards, principles and approaches embodied in the ILO Occupational Health Services Convention, 1985 (No. 161) and its accompanying Recommendation (No. 171); ILO Occupational Safety and Health Convention, 1981 (No. 155) and its accompanying Recommendation (No. 164); and the Working Document of the Twelfth Session of the Joint ILO/WHO Committee on Occupational Health, 5-7 April 1995. The ILO Occupational Health Services Convention (No. 161) defines “occupational health services” as services entrusted with essentially preventive functions and responsible for advising the employer, the workers and their representatives in the undertaking on the requirements for establishing and maintaining a safe and healthy working environment which will facilitate optimal physical and mental health in relation to work and the adaptation of work to the capabilities of workers in the light of their state of physical and mental health. Provision of occupational health services means carrying out activities in the workplace with the aim of protecting and promoting workers’ safety, health and well-being, as well as improving working conditions and the working environment. These services are provided by occupational health professionals functioning individually or as part of special service units of the enterprise or of external services. Occupational health practice is broader and consists not only of the activities performed by the occupational health service. It is multidisciplinary and multisectoral activity involving in addition to occupational health and safety professionals other specialists both in the enterprise and outside, as well as competent authorities, the employers, workers and their representatives. -
Page 1 the Public Health Benefits of Sanitation Interventions
The Public Health Benefits of Sanitation Interventions EPAR Brief No. 104 Jacob Lipson, Professor Leigh Anderson & Professor Susan Bolton Prepared for the Water & Sanitation Team of the Bill & Melinda Gates Foundation Evans School Policy Analysis and Research (EPAR) Professor Leigh Anderson, PI and Lead Faculty Associate Professor Mary Kay Gugerty, Lead Faculty December 10, 2010 Introduction Limited sanitation infrastructure, poor hygienic practices, and unsafe drinking water negatively affect the health of millions of people in the developing world. Using sanitation interventions to interrupt disease pathways can significantly improve public health.1 Sanitation interventions primarily benefit public health by reducing the prevalence of enteric pathogenic illnesses, which cause diarrhea. Health benefits are realized and accrue to the direct recipients of sanitation interventions and also to their neighbors and others in their communities. In a report to the United Nations Development Programme (UNDP), Hutton et al. (2006) estimate that the cost- benefit ratio of sanitation interventions in all developing countries worldwide is 11.2.2 This literature review summarizes the risks of inadequate sanitation to public health and presents the empirical evidence on the public health benefits of complete, intermediate and multiple factor sanitation interventions. The sanitation literature frequently uses inconsistent terminology to describe sanitation infrastructure, technologies and intervention types. Where feasible, we report study results using the original terminology of the authors, while also using consistent terminology to facilitate comparisons across studies. In this review and in much of the literature, sanitation interventions are defined as improvements which provide public or household fecal disposal facilities, and/or improve community fecal disposal and treatment methods.3,4 Sanitation interventions are distinct from water interventions, which focus on increasing access to clean water or improving water quality at drinking water sources or points of use. -
2021 Onsite Employee Health Clinics Summit
2021 Onsite Employee Health Clinics Summit The Leading Forum on Building & Expanding On-Site Health Clinics – Incorporating Strategies that Reduce Costs, Ensure Employee Satisfaction and Positively Impact Patient Behavior January 28 – 29, 2021 • DoubleTree Resort by Hilton Paradise Valley • Scottsdale, AZ List of Past Attendees Title Company Director, Human Resources City of Douglasville, Georgia CAO Phil Long Dealerships Managing Director H4D Administrator Decorator Industries Vice President of Sales CareATC Account Executive Merck & Co., Inc. Operations Manager Healthcare Solutions Center, LLC CEO Northwind Pharmaceuticals Business Strategist Occupational Health Solutions COO Northwind Pharmaceuticals Wellness Coordinator City of Phoenix Vice President Business Development ChristianaCare National Association of Worksite Health Executive Director Centers Sr Director, Human Resources Tucson Electric Power President Health Cost & Risk Management LLC VP, Operations Premise Health Director, Employee Benefits & Well-being Herman Miller, Inc. Regional Director North Ms. Medical Clinics Director Wellness Programs Tahoe Forest Hospital VP HR & Risk Management Phil Long Dealerships Director of Clinic Operations Baylor Scott & White CEO Moss CM National Director-Employers Amgen SR. VP Human Resources and Foundation La Posada Acting CEO Southern Indian Health Council VP, Operations Premise Health Associate OMERS Private Equity Manager Stanford Healthcare New Business Development Manager Roche Diabetes Care Chief Executive Officer Premise Health -
How to Justify Your Occupational Medicine Program to Your C-Suites
V WINTER 2020 THE PERIODICALisions OF THE NATIONAL ASSOCIATION OF OCCUPATIONAL HEALTH PROFESSIONALS “The Internal Sell” – How to Justify Your Occupational Medicine Program to Your C-Suites By Randy Van Straten, Vice President, Business & Community Health, Bellin Health he key to justifying an occupational medicine program to your C-Suites is simple. Helping employers with an Toccupational health program is just plain, good business for health systems. How do you go about the tough sell? his starts with working with your own health system as an occupational health employer customer, producing results, and demonstrating bottom-line value directly to the health system; this is called starting in the walls. he next step is to move beyond the walls to your community employers, creating a durable competitive advantage in the market place establishing a market channel continued on page 4 Page 6 Page 8 Page 10 Page 12 Page 28 IME Approaches to Mentorship Occmed Sales Sponsor Services Behavioral Health ['mentôrSHip, and Marketing Highlight: in the Workplace 'mentərSHip] NetHealth Welcoming in 2020 he beginning of a new year is a time of opportunity. It is a time to relect on the past year, celebrate the wins, take stock of losses, and make plans for the future. A new year means new What Is the NAOHP? resolutions. Will you resolve to be healthier, exercise more; NAOHP is that special “niche” most spend less time on your phone, be more present? Is it time for a professionals (both non-clinical and clinical) are looking for. We help ill new job, inally seek that promotion, to retire? the need for education, training, How are you about your occupational health program? Is stafing models, repairing operational your vision 2020? issues, improving infrastructure, and If your organization is like most, considerable time was integrating additional services such as Heather spent, at some point, creating a vision statement focused on urgent care, telemedicine, wellness, Manley the future of the organization and the industry. -
David A. Sterling, Phd, CIH, ROH, FAIHA CURRICULUM VITA
David A. Sterling, PhD, CIH, ROH, FAIHA CURRICULUM VITA Work Address and Contact Information School of Public Health University of North Texas Health Science Center 3500 Camp Bowie Blvd Fort Worth, TX 76107 phone: (817) 735-5098 email: [email protected] https://www.unthsc.edu/school-of-public-health/dr-david-sterling/ EDUCATION Degrees Ph.D. Environmental and Occupational Health Science, June 1986, The University of Texas School of Public Health, Houston, Texas. M.Sc. Environmental Health Science/Industrial Hygiene. August 1982, University of Cincinnati College of Medicine, Institute of Environmental Health, Kettering Laboratory, Cincinnati, Ohio. B.Sc. Biological Sciences. December 1978, University of Oregon, Eugene, Oregon. Undergraduate work in Humanities, Sciences and Computer Science. 1973-1978. Simon Fraser University, Vancouver, B.C., Canada. Certifications Certified in the Comprehensive Practice of Industrial Hygiene by the American Board of Industrial Hygiene. CIH #3969 Awarded June 1988. Most recent recertification review approval July 2015 – December 1, 2020. Registered Occupational Hygienist by the Canadian Registration Board of Occupational Hygienists. ROH #198 Awarded January 1989. Most recent registration maintenance review approval January 1, 2015 – December 31, 2019. Honors Asthma 411 ‘Team’ selected as 2018 Health Care Heroes by the Fort Worth Business Press for their advocacy work on building a collaborative to spread Asthma 411 throughout the city and county, February 8, 2018. (Dr. Sterling is the developer of Asthma 411 – A K-12 School-based asthma initiative). The annual Health Care Heroes Awards recognizes excellence in the medical community. Each year it is awarded to outstanding physicians, administrators, volunteers and other dedicated individuals. -
Price List of Vaccinations at Public Health Clinics
DHHS PUBLIC HEALTH CLINIC IMMUNIZATION PRICE LIST (707) 268-2108 Insured adults and children will no longer be eligible to receive low-cost, federally subsidized vaccinations. This holds true even if the insurance includes a high deductible or co-pay. The vaccinations can be purchased, however. The fees below are subject to change; please call if you need to confirm a price, or if you have questions about what vaccines you need, or about your vaccine cost. A child without privately purchased insurance will still be eligible to receive low-cost, federally subsidized vaccinations if he or she is: § uninsured (does not have private health insurance); or is § American Indian or Alaskan Native. CHILD DTaP (Diphtheria, Tetanus, Pertussis)…………………………………………$54.00 per dose Hepatitis A …………………………………………………………………….$56.00 per dose Hepatitis B……………………………………………………………………..$51.00 per dose HIB (Haemophilus Influenzae Type b)………………………………………...$60.00 per dose HPV (Human Papillomavirus)…………………………………………………$202.00 per dose Influenza……………………………………………………………………….$17.00 donation IPV (Polio)……………………………………………………………………...$65.00 per dose Menactra (Meningococcal conjugate)…………………………………………$149.00 per dose MMR (Measles, Mumps, Rubella)……………………………………………..$100.00 per dose PCV13 (Pneumococcal Conjugate)…………………………………………….$166.00 per dose Rotovirus……………………………………………………………………….$110.00 per dose TB Test (PPD)………………………………………………………………….$25.00 Td (Tetanus, Diphtheria)………………………………………………………..$55.00 per dose TdaP (Tetanus, Diphtheria, Pertussis)………………………………………….$70.00 per dose Typhoid -
CDC's Global Water, Sanitation, and Hygiene (WASH) Program Impact
CDC’s Global Water, Sanitation, and Hygiene (WASH) Program Impact Objective The Centers for Disease Control and Prevention’s (CDC’s) global WASH program provides expertise and interventions aimed at saving lives and reducing illness through global access to safe water, adequate sanitation, and improved hygiene. These prevention and control measures reduce the impact of WASH- Where we work: related diseases by improving health, reducing poverty, and increasing economic development. Afghanistan Angola Bangladesh Program Description Burkina Faso CDC’s WASH program works with partners in every WHO region and focuses on: Burma Burundi Making Water Safe to Drink: Promoting safe water through CDC’s Safe Water System (SWS) and Cameroon development and implementation of Water Safety Plans (WSPs). Colombia D. R. of Congo Improving Hygiene and Sanitation to Prevent the Spread of Disease: Improving the efficacy, Ecuador sustainability, and integration of hygiene and sanitation interventions. El Salvador Ethiopia Responding to International Emergencies and Outbreaks: Deploying emergency response and Ghana outbreak investigation teams at the request of foreign governments. Guatemala Guinea Controlling and Eliminating Disease: Identifying WASH-related factors needed to control or Guyana eliminate Neglected Tropical Diseases (NTDs) like Guinea worm disease. Haiti Honduras Identifying and Characterizing Disease: Investigating the agents and causes of illness, such as India diarrhea, to provide critical health data for decision making. Jamaica Kenya Training and Educating about Global WASH: Developing model programs and materials for Liberia public health staff training and community health promotion. Laos Madagascar Malawi Mozambique Public Health Impact Nepal More than 30 countries treated over 90 billion liters of water using SWS programs. -
Understanding the Effects of Poor Sanitation on Public Health
Understanding the Effects of Poor Sanitation on Public Health, the Environment and Well-being Report of a study conducted in Homa Bay, Elgeyo Marakwet and Kericho counties in Kenya June 2018 Kenya Country Office Ngong Lane, off Ngong Road P.O. Box 30776, 00100 Nairobi, Kenya Tel.: +254 724 463355 Email: [email protected] Executive Summary Poor sanitation is linked to diarrhoeal diseases, which are among the leading causes of morbidity and mortality in children under five. It is also associated with a number of infectious and nutritional outcomes which have great bearing on the health and well-being of the child. The Sustainable Sanitation and Hygiene for All (SSH4A) project from SNV Netherlands Development Organisation (SNV) supports the improvement of sanitation services in four counties in Kenya, to help them address some of the pressing challenges they face in providing sanitation for all. This study was commissioned by the Voice for Change Partnership (V4CP) programme to gain more insights into the effects of poor sanitation on public health, the environment and well-being in Kericho, Homa Bay and Elgeyo Marakwet counties. It is expected that these counties will learn from these findings and take steps to improve their water, sanitation and hygiene activities. The findings from the case-control study show that, in general, case households had a bigger burden of sanitation-related disease than control families: slightly more households in the case category had a family member who was treated for sanitation-related illness in the six months before the survey than in the control group. Analysis of disease burden across the three counties shows the households in Homa Bay had experienced a higher burden of sanitation-related illnesses in the previous six months than the other two counties. -
Evaluating and Reporting Persons Under Investigation (PUI) Summary of Recent Changes
Coronavirus Disease 2019 (COVID-19) Evaluating and Reporting Persons Under Investigation (PUI) Summary of Recent Changes Revisions were made on March 4, 2020, to reflect the following: Criteria for evaluation of Persons Under Investigation (PUI) were expanded to a wider group of symptomatic patients. Revisions were made on February 28, 2020, to reflect the following: Updated recommendations for specimen collection. Updated March 4, 2020 Limited information is available to characterize the spectrum of clinical illness associated with coronavirus disease 2019 (COVID-19). No vaccine or specific treatment for COVID-19 is available; care is supportive. The CDC clinical criteria for a COVID-19 person under investigation (PUI) have been developed based on what is known about COVID-19 and are subject to change as additional information becomes available. Contact your local or state health department ! Healthcare providers should immediatelyimmediately notify their local " or state " health department in the event of a PUI for COVID-19. Criteria to Guide Evaluation of PUI for COVID-19 As availability of diagnostic testing for COVID-19 increases, clinicians will be able to access laboratory tests for diagnosing COVID-19 through clinical laboratories performing tests authorized by FDA under an Emergency Use Authorization (EUA). Clinicians will also be able to access laboratory testing through public health laboratories in their jurisdictions. This expands testing to a wider group of symptomatic patients. Clinicians should use their judgment to determine if a patient has signs and symptoms compatible with COVID-19 and whether the patient should be tested. Decisions on which patients receive testing should be based on the local epidemiology of COVID-19, as well as the clinical course of illness.